• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Mutational analysis of the p53 and K-ras genes and allelotype study of the Rb-1 gene for investigating the pathogenesis of combined hapatocellular-cholangiocellular carcinomas.对p53和K-ras基因进行突变分析以及对Rb-1基因进行等位基因分型研究,以探讨肝内胆管癌合并肝细胞癌的发病机制。
Jpn J Cancer Res. 1996 Oct;87(10):1056-62. doi: 10.1111/j.1349-7006.1996.tb03110.x.
2
Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand.日本和泰国肝内胆管细胞癌中p53肿瘤抑制基因和ras基因家族的突变
Mol Carcinog. 1993;8(4):312-8. doi: 10.1002/mc.2940080415.
3
A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma.肝细胞癌与胆管癌合并的组织病理学研究:胆管癌成分起源于肝细胞癌。
Hepatogastroenterology. 2007 Mar;54(74):508-13.
4
[The significance of immunohistochemistry in the investigation of liver neoplasms: differential diagnosis, prognostic markers].[免疫组织化学在肝脏肿瘤研究中的意义:鉴别诊断、预后标志物]
Vopr Onkol. 2008;54(4):417-33.
5
Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.人类肝细胞癌中肿瘤抑制基因p53和视网膜母细胞瘤基因的畸变。
Cancer Res. 1991 Oct 15;51(20):5520-5.
6
Mutational landscape of combined hepatocellular carcinoma and cholangiocarcinoma, and its clinicopathological significance.肝细胞癌合并胆管癌的突变图谱及其临床病理意义。
Histopathology. 2017 Feb;70(3):423-434. doi: 10.1111/his.13084. Epub 2016 Nov 15.
7
An immunohistochemical analysis of 13 cases with combined hepatocellular and cholangiocellular carcinoma.13例肝细胞癌合并胆管细胞癌的免疫组织化学分析。
Liver. 1995 Feb;15(1):9-15. doi: 10.1111/j.1600-0676.1995.tb00099.x.
8
Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study.肝细胞-胆管细胞癌合并症。一项组织学与免疫组织化学研究。
Cancer. 1985 Jan 1;55(1):124-35. doi: 10.1002/1097-0142(19850101)55:1<124::aid-cncr2820550120>3.0.co;2-z.
9
Occurrence of hepatocellular and cholangiocellular carcinoma in different hepatic lobes.肝细胞癌和胆管细胞癌在不同肝叶中的发生情况。
Hepatogastroenterology. 2003 Jan-Feb;50(49):65-8.
10
Updates in the diagnosis of combined hepatocellular-cholangiocarcinoma.联合肝细胞癌-胆管细胞癌的诊断进展。
Hum Pathol. 2020 Feb;96:48-55. doi: 10.1016/j.humpath.2019.11.001. Epub 2020 Jan 10.

引用本文的文献

1
Combined hepatocellular-cholangiocarcinoma: a population level analysis of incidence and mortality trends.肝细胞癌-胆管细胞癌混合型:发病率和死亡率趋势的人群水平分析。
World J Surg Oncol. 2019 Feb 27;17(1):43. doi: 10.1186/s12957-019-1586-8.
2
A genetic database can be utilized to identify potential biomarkers for biphenotypic hepatocellular carcinoma-cholangiocarcinoma.基因数据库可用于识别双表型肝细胞癌-胆管癌的潜在生物标志物。
J Gastrointest Oncol. 2016 Aug;7(4):570-9. doi: 10.21037/jgo.2016.04.01.
3
Combined hepatocellular cholangiocarcinoma: Controversies to be addressed.肝细胞胆管癌合并症:有待解决的争议。
World J Gastroenterol. 2016 May 14;22(18):4459-65. doi: 10.3748/wjg.v22.i18.4459.
4
Genetic profiling of intrahepatic cholangiocarcinoma.肝内胆管癌的基因谱分析。
Curr Opin Gastroenterol. 2012 May;28(3):266-72. doi: 10.1097/MOG.0b013e3283523c7e.
5
Synchronous development of HCC and CCC in the same subsegment of the liver in a patient with type C liver cirrhosis.丙型肝硬化患者肝脏同一亚段内同时发生肝细胞癌和肝内胆管癌。
World J Hepatol. 2009 Oct 31;1(1):103-9. doi: 10.4254/wjh.v1.i1.103.
6
Outcome of combined hepatocellular and cholangiocarcinoma of the liver.肝合并肝细胞癌和胆管细胞癌的结果。
J Oncol. 2010;2010. doi: 10.1155/2010/917356. Epub 2010 Sep 2.
7
Combined hepatocholangiocarcinoma: case-series and review of literature.肝内胆管癌合并症:病例系列及文献综述
Int J Gastrointest Cancer. 2006;37(1):27-34. doi: 10.1385/IJGC:37:1:27.
8
Immunohistochemical analysis of p53, cyclinD1, RB1, c-fos and N-ras gene expression in hepatocellular carcinoma in Iran.伊朗肝细胞癌中p53、细胞周期蛋白D1、RB1、c-fos和N-ras基因表达的免疫组织化学分析
World J Gastroenterol. 2007 Jan 28;13(4):588-93. doi: 10.3748/wjg.v13.i4.588.
9
Simultaneous presentation of hepatocellular carcinoma in identical twin brothers.
Med Oncol. 2002;19(2):113-6. doi: 10.1385/MO:19:2:113.
10
Immunohistochemical study on p53, H-rasp21, c-erbB-2 protein and PCNA expression in HCC tissues of Han and minority ethnic patients.汉族及少数民族肝癌患者癌组织中p53、H-rasp21、c-erbB-2蛋白及PCNA表达的免疫组化研究
World J Gastroenterol. 2000 Apr;6(2):234-238. doi: 10.3748/wjg.v6.i2.234.

本文引用的文献

1
Combined liver cell and bile duct carcinoma.肝细胞胆管癌合并症
Am J Pathol. 1949 Jul;25(4):647-55.
2
Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma.人类肝细胞癌中13号染色体长臂缺失、视网膜母细胞瘤1基因突变及视网膜母细胞瘤蛋白状态
Cancer Res. 1994 Aug 1;54(15):4177-82.
3
Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction.采用荧光多重聚合酶链反应检测结直肠癌中DCC、p53、RBI、WT1、NF1、NM23和APC/MCC等位基因缺失的频率。
Br J Cancer. 1994 Nov;70(5):813-8. doi: 10.1038/bjc.1994.404.
4
Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features and computed tomographic findings.肝细胞癌合并胆管癌:临床特征与计算机断层扫描表现
Hepatology. 1993 Nov;18(5):1090-5.
5
Ki-ras mutations and p53 protein expressions in intrahepatic cholangiocarcinomas: relation to gross tumor morphology.肝内胆管癌中Ki-ras突变与p53蛋白表达:与肿瘤大体形态的关系
Gastroenterology. 1995 Nov;109(5):1612-7. doi: 10.1016/0016-5085(95)90650-9.
6
Structure and organization of the human Ki-ras proto-oncogene and a related processed pseudogene.人类Ki-ras原癌基因及一个相关的加工假基因的结构与组织
Nature. 1983;304(5926):501-6. doi: 10.1038/304501a0.
7
Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.抗生物素蛋白-生物素-过氧化物酶复合物(ABC)在免疫过氧化物酶技术中的应用:ABC法与未标记抗体(PAP)法的比较。
J Histochem Cytochem. 1981 Apr;29(4):577-80. doi: 10.1177/29.4.6166661.
8
Analysis of DNA extracted from formalin-fixed, paraffin-embedded tissues by enzymatic amplification and hybridization with sequence-specific oligonucleotides.通过酶促扩增及与序列特异性寡核苷酸杂交对从福尔马林固定、石蜡包埋组织中提取的DNA进行分析。
Biochem Biophys Res Commun. 1987 Feb 13;142(3):710-6. doi: 10.1016/0006-291x(87)91472-0.
9
Structure and partial genomic sequence of the human retinoblastoma susceptibility gene.
Gene. 1989 Aug 1;80(1):119-28. doi: 10.1016/0378-1119(89)90256-4.
10
Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study.肝细胞-胆管细胞癌合并症。一项组织学与免疫组织化学研究。
Cancer. 1985 Jan 1;55(1):124-35. doi: 10.1002/1097-0142(19850101)55:1<124::aid-cncr2820550120>3.0.co;2-z.

对p53和K-ras基因进行突变分析以及对Rb-1基因进行等位基因分型研究,以探讨肝内胆管癌合并肝细胞癌的发病机制。

Mutational analysis of the p53 and K-ras genes and allelotype study of the Rb-1 gene for investigating the pathogenesis of combined hapatocellular-cholangiocellular carcinomas.

作者信息

Imai Y, Oda H, Arai M, Shimizu S, Nakatsuru Y, Inoue T, Ishikawa T

机构信息

Department of Pathology, Faculty of Medicine, University of Tokyo, Bunkyo-ku, Japan.

出版信息

Jpn J Cancer Res. 1996 Oct;87(10):1056-62. doi: 10.1111/j.1349-7006.1996.tb03110.x.

DOI:10.1111/j.1349-7006.1996.tb03110.x
PMID:8957064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5921002/
Abstract

Because combined hepatocellular-cholangiocellular carcinoma is rare and its biological features and pathogenesis have not been well established, we investigated alterations of the p53, K-ras and Rb-1 genes, as well as expression patterns of carcinoembryonic antigen and keratin, in seven combined hepatocellular-cholangiocarcinomas out of 557 hepatocellular carcinomas autopsied at Tokyo University during 30 years. Mutations of the p53 gene were found in two cases, at codon 244 (GGC to TGC) in the cholangiocellular carcinoma component of case 1 (mixed type, showing an intimate intermingling of both elements) and at codon 234 (TAC to AAC) in both components of case 5 (combined type, consisting of contiguous but independent masses of both elements). Mutation of the K-ras gene (codon 12, GGT to GAT) was seen only in the cholangiocellular carcinoma component of clinically apparent double cancer, case 6. Allelic alteration of the Rb-1 gene was observed in two cases, deletion of both alleles in the hepatocellular carcinoma component of case 3 (combined type) and replication error of the same pattern in both components of case 4 (mixed type). Immunohistochemical analysis showed that the hepatocellular carcinoma components of five cases (cases 2, 3, 5, 6, 7) were immunoreactive for keratin, suggesting biliary epithelial transformation. In four of the five cases (cases 3 and 5 combined, case 7 mixed and case 6 double cancer), cholangiocellular carcinoma components were also positive for keratin. These results suggest that both components of combined hepatocellular-cholangiocarcinoma have the same genetic and phenotypic character and might have arisen from the same origin in some cases.

摘要

由于肝内胆管癌合并肝细胞癌较为罕见,其生物学特性及发病机制尚未完全明确,我们对东京大学30年间尸检的557例肝细胞癌中的7例肝内胆管癌合并肝细胞癌进行了研究,检测了p53、K-ras和Rb-1基因的改变,以及癌胚抗原和角蛋白的表达模式。在2例病例中发现了p53基因突变,1号病例(混合型,两种成分紧密交织)的胆管细胞癌成分中密码子244(GGC突变为TGC)发生突变,5号病例(联合型,由两种成分相邻但独立的肿块组成)的两种成分中密码子234(TAC突变为AAC)发生突变。K-ras基因(密码子12,GGT突变为GAT)的突变仅见于临床诊断为双癌的6号病例的胆管细胞癌成分。在2例病例中观察到Rb-1基因的等位基因改变,3号病例(联合型)的肝细胞癌成分中两个等位基因均缺失,4号病例(混合型)的两种成分中出现相同模式的复制错误。免疫组化分析显示,5例病例(2、3、5、6、7号病例)的肝细胞癌成分对角蛋白呈免疫反应性,提示胆管上皮化生。在这5例病例中的4例(3号和5号病例联合、7号病例混合型和6号病例双癌),胆管细胞癌成分对角蛋白也呈阳性。这些结果表明,肝内胆管癌合并肝细胞癌的两种成分具有相同的遗传和表型特征,在某些情况下可能起源相同。